Meet the Startup Using Dogs to Sniff Out Cancer

Meet the Startup Using Dogs to Sniff Out Cancer

Israeli cancer diagnostics startup SpoititEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients’ breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year. The post Meet the Startup Using Dogs to Sniff Out Cancer appeared first on MedCity News.

SpotitEarly Enters U.S. Market with $20M+ to Revolutionize At-Home Early Cancer Detection

The Company’s Cancer Detection Technology has Achieved a 94 Percent Accuracy Rate, Attracting Top Investors, Researchers, and Academic Medical Centers ENGLEWOOD, N.J.–(BUSINESS WIRE)–SpotitEarly, a biotech startup focused on transforming cancer screening by harnessing the power of artificial intelligence and canines to analyze volatile organic compounds (VOCs) in breath samples and detect cancer at its earliest stages, today officially launched …

SpotitEarly launches in U.S. with $20.3M to detect cancer using AI

SpotitEarly, a biotech startup that uses AI and dogs to detect cancer using an at-home test, announced its launch into the U.S. market with $20.3 million in funding.  The company has received funding from Menomedin VC, Jeff Swartz (former CEO of Timberland), Avishai Abrahami (CEO of Wi), Hanaco VC and others.  Additionally, SpotitEarly was awarded grants, including one from the BIRD Foundation, which funds research and development between Israel…

AI biotech firm SpotitEarly raises $20.3M to scale noninvasive cancer detection in US - SiliconANGLE

Israeli artificial intelligence biotech startup SpotitEarly Ltd. today officially launched in the U.S. and announced that it has raised $20.3 million in new funding to scale up its U.S. presence and to strengthen its cancer detection technology. Founded in 2020, SpotitEarly is pioneering a noninvasive breath test for early cancer detection. The company uses AI […] The post AI biotech firm SpotitEarly raises $20.3M to scale noninvasive cancer det…

SpotitEarly Enters U.S. Market with $20.3M for AI & Canine-Powered Cancer Test

What You Should Know: –  SpotitEarly, a biotech company pioneering a non-invasive approach to early cancer detection, has officially launched its U.S. operations following a $20.3 million funding round. –  The company aims to revolutionize cancer screening through its breath-based diagnostic platform, which integrates advanced AI with canine scent detection to identify cancer-associated volatile organic compounds (VOCs) with 94% accuracy, as dem…